GenBioPro Can Defend FDA Approval In Mifepristone Suit

By Dan McKay · April 29, 2025, 5:46 PM EDT

A Texas federal judge has allowed drugmaker GenBioPro to join a legal fight over access to the abortion drug mifepristone, finding that the company has a distinct interest in defending federal...

To view the full article, register now.

Documents

Case Information

Case Title

State of Missouri et al v. U.S. Food and Drug Administration et al

Case Number

2:22-cv-00223

Court

Texas Northern

Nature of Suit

Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

November 18, 2022